Indian J Pharm Close
 

Figure 3: Nitric-oxide release by HIG-82 cell line induced with IL-1β and treated with formulations. HIG-82 cells were induced with IL-1β for 72 h, cells were treated with formulation and extract (a) Ashwagandharishta, Balarishta, and Dashmoolarishta (b) Triphala for 24h and cell supernatant was analyzed for nitric-oxide using Griess reagent., “a” expressed as significance when compared to control, “b” expressed significance when compared to IL-1β treated cells. ** P < 0.01; *** P < 0.001 (Ash = Ashwagandharishta, Bal = Balarishta, and Dash = Dashmoolarishta)

Figure 3: Nitric-oxide release by HIG-82 cell line induced with IL-1β and treated with formulations. HIG-82 cells were induced with IL-1β for 72 h, cells were treated with formulation and extract (a) <i>Ashwagandharishta</i>, <i>Balarishta</i>, and <i>Dashmoolarishta</i> (b) <i>Triphala</i> for 24h and cell supernatant was analyzed for nitric-oxide using Griess reagent., “a” expressed as significance when compared to control, “b” expressed significance when compared to IL-1β treated cells. ** <i>P</i> < 0.01; *** <i>P</i> < 0.001 (Ash = <i>Ashwagandharishta</i>, Bal = <i>Balarishta</i>, and Dash = <i>Dashmoolarishta</i>)